Halfway Into 2014, Pharma M&A Still Booming
Continued consolidation, a ripe mergers and acquisitions market and an all-out fight for market share have kept drug companies buzzing with deals through the first six months of 2014, and the...To view the full article, register now.
Already a subscriber? Click here to view full article